Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Equity (2017 - 2025)

Integra Lifesciences Holdings' Return on Equity history spans 16 years, with the latest figure at 0.5% for Q4 2025.

  • For Q4 2025, Return on Equity fell 49.0% year-over-year to 0.5%; the TTM value through Dec 2025 reached 0.5%, down 49.0%, while the annual FY2025 figure was 0.4%, 39.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.5% at Integra Lifesciences Holdings, down from 0.48% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.13% in Q3 2021 and bottomed at 0.5% in Q4 2025.
  • The 5-year median for Return on Equity is 0.07% (2023), against an average of 0.01%.
  • The largest annual shift saw Return on Equity grew 14bps in 2021 before it crashed -49bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.1% in 2021, then increased by 0bps to 0.1% in 2022, then plummeted by -58bps to 0.04% in 2023, then plummeted by -111bps to 0.0% in 2024, then plummeted by -10863bps to 0.5% in 2025.
  • Per Business Quant, the three most recent readings for IART's Return on Equity are 0.5% (Q4 2025), 0.48% (Q3 2025), and 0.39% (Q2 2025).